Experienced in Vasculitis

Dr. Kevin R. Bender

Cardiology
Central Medical Group, PA
3000 Coral Hills Dr, 
Coral Springs, FL 
Accepting New Patients
Offers Telehealth
Experienced in Vasculitis
Central Medical Group, PA
3000 Coral Hills Dr, 
Coral Springs, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kevin Bender is a Cardiologist in Coral Springs, Florida. Dr. Bender is rated as an Experienced provider by MediFind in the treatment of Vasculitis. His top areas of expertise are Mitral Valve Regurgitation, Unstable Angina, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Bender is currently accepting new patients.

His clinical research consists of participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in FL
Hospital Affiliations
University Hospital And Medical Center
Boca Raton Regional Hospital
Broward Health Coral Springs
Broward Health Imperial Point
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

CENTRAL MEDICAL GROUP PA
3000 Coral Hills Dr, Coral Springs, FL 33065
Other Locations
CENTRAL MEDICAL GROUP PA
6610 N University Dr, Suite 120, Tamarac, FL 33321
CENTRAL MEDICAL GROUP PA
7707 N University Dr, Suite 106, Tamarac, FL 33321

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
Enrollment Status: Completed
Publish Date: May 17, 2023
Intervention Type: Drug
Study Drug: PUL-042 Inhalation Solution
Study Phase: Phase 2
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
A Phase 2 Multiple Dose Study to Evaluate the Efficacy and Safety of PUL-042 Inhalation Solution in Reducing the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Drug
Study Drug: PUL-042 Inhalation Solution
Study Phase: Phase 2
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials
Similar Doctors
Distinguished in Vasculitis
Dr. Roberto A. Miki
Cardiology
Distinguished in Vasculitis
Dr. Roberto A. Miki
Cardiology
1295 Nw 14th Street, Suite A, 
Miami, FL 
 (33.3 miles away)
305-243-5879
Languages Spoken:
English
See accepted insurances

Roberto Miki is a Cardiologist in Miami, Florida. Dr. Miki is rated as a Distinguished provider by MediFind in the treatment of Vasculitis. His top areas of expertise are Ectopic Heartbeat, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Paroxysmal Supraventricular Tachycardia (PSVT), and His Bundle Tachycardia.

Advanced in Vasculitis
Dr. Ali A. Bazzi
Cardiology
Advanced in Vasculitis
Dr. Ali A. Bazzi
Cardiology

South Florida International Cardiology Consultants, Inc.

3801 Biscayne Blvd, Suite 300, 
Miami, FL 
 (31.8 miles away)
305-571-0620
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Ali Bazzi is a Cardiologist in Miami, Florida. Dr. Bazzi is rated as a Distinguished provider by MediFind in the treatment of Vasculitis. His top areas of expertise are Heart Murmurs, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Metabolic Syndrome. Dr. Bazzi is currently accepting new patients.

Advanced in Vasculitis
Dr. David S. Funt
Cardiology
Advanced in Vasculitis
Dr. David S. Funt
Cardiology
9980 Central Park Blvd N, Suite 304, 
Boca Raton, FL 
 (7.0 miles away)
561-483-8335
Languages Spoken:
English, French, Spanish
See accepted insurances
Accepting New Patients

David Funt is a Cardiologist in Boca Raton, Florida. Dr. Funt is rated as a Distinguished provider by MediFind in the treatment of Vasculitis. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Mitral Valve Regurgitation, and Arrhythmias. Dr. Funt is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bender's expertise for a condition
ConditionClose
      View All 38 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile